Page last updated: 2024-08-22

2-amino-1,3,4-thiadiazole and Leishmaniasis, American

2-amino-1,3,4-thiadiazole has been researched along with Leishmaniasis, American in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amaral, VF; Canto-Cavalheiro, MM; Charret, KS; da Silva, EF; Echevarria, A; Leon, LL; Rodrigues, RF1
Amaral, V; Campos, MC; Canto-Cavalheiro, MM; Charret, KS; Dos Reis, C; Echevarria, A; Leon, LL; Rodrigues, RF1

Other Studies

2 other study(ies) available for 2-amino-1,3,4-thiadiazole and Leishmaniasis, American

ArticleYear
Antileishmanial activity of 1,3,4-thiadiazolium-2-aminide in mice infected with Leishmania amazonensis.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2

    Topics: Animals; Antiprotozoal Agents; Blood Cell Count; Leishmania mexicana; Leishmaniasis, Cutaneous; Lymph Nodes; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred CBA; Nitric Oxide; Organometallic Compounds; Structure-Activity Relationship; Thiadiazoles

2009
The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:1

    Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Leishmania infantum; Leishmania mexicana; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Thiadiazoles; Treatment Outcome

2012